DrazCanna, Inc. (OTCBB: DZCA) Announces Actions for Entry into Emerging Growth Cannabis Bio-Pharmaceutical Research and Development Supply Chain
Cannabis Bio-Pharmaceutical Research and Development company announces shareholder approval of pending Reverse Merger, Selection of Auditors for Fiscal Year End 2022, location for DrazCanna's Detroit Center...
Drazcanna, Inc. Announces Filing With USPTO For Provisional Patent Developed Upon Marijuana Cultivation To Aid Food Industry In Combatting Effects Of Global Warming
Cannabis Bio-Pharmaceutical Research and Development company announces Letters of Intent signed to transfer rights of the Nutrient Optimizing Data-Driven Hydroponic System for indoor/hybrid greenhouse...